financial results

Alibaba Group (BABA) reported its Q3 2025 financial results, showcasing increased revenue (5% YoY, 15% excluding disposed businesses) but decreased profitability due to strategic investments in AI and cloud infrastructure. AI product revenue saw triple-digit growth. The company’s focus is on long-term value creation through AI technologies and expanding its consumption platform. Key segments like China e-commerce and Cloud Intelligence showed strong revenue growth, particularly fueled by AI. Alibaba is actively repurchasing shares, signaling confidence in its future.

Vivoryon Therapeutics (VVY) will release its Q3 2025 financial results and operational progress on December 4, 2025. A conference call and webcast will be held at 3:00 pm CET / 9:00 am EST. The webcast will be available on Vivoryon’s investor relations site. Participants planning to dial in are encouraged to pre-register for expedited access and to call in 15 minutes early. The company will provide an update on its varoglutamstat program for diabetic kidney disease.

Qudian Inc. reported its Q3 2025 unaudited financial results, revealing a sharp 84.5% drop in revenue to RMB8.5 million due to the last-mile delivery business phase-out. However, net income attributable to shareholders surged to RMB409.9 million, driven by increased investment income and gains on derivative instruments. The company maintains a strong cash position and continues its share repurchase program. Qudian’s future hinges on successful diversification and strategic capital allocation.

Vext Science Inc. (VEXTF) reported strong Q3 2025 results, with revenue up 41% year-over-year to $12.7 million. This growth was fueled by expanded retail operations in Ohio and resilient performance in Arizona. Year-to-date operating cash flow reached $8.5 million, a significant improvement from the previous year. Vext is on track to reach the Ohio dispensary license cap of eight by 2026, positioning itself for continued growth in the adult-use market. The company maintains a focus on maximizing dispensary performance and strategic expansion.

JOYY Inc. reported unaudited Q3 2025 financial results with $540 million in revenue, a 6.4% quarter-over-quarter increase. Livestreaming revenue reached $388 million, up 3.5% sequentially. BIGO Ads saw a 33.1% year-over-year revenue increase to $104 million. GAAP and non-GAAP operating income rose by approximately 19.1% and 16.6%, respectively. The company held $3.32 billion in net cash. JOYY is executing a $900 million shareholder return program, having distributed $148 million in dividends and repurchased $89 million in shares.

Scientific Industries (SCND) reported Q3 2025 results, including revenue of $1.404 million, a 45.5% gross margin, and net income of $3.994 million ($0.34 EPS). They hold $8.3 million in cash, equivalents, and investments (Sep 30, 2025). The Genie division sale boosted results. VIVID sales rose 27% YoY, Torbal division sales increased 15% YTD. An AI enhancement was launched for the VIVID WORKSTATION, and a second generation VIVID-ONE is scheduled for Q1 CY26.

Hillenbrand, Inc. reported Q4 and FY2025 results, excluding the divested Milacron business. Q4 net revenue was $652 million, a 22% decrease (5% pro forma). GAAP EPS was $1.07, up from $0.17, while adjusted EPS decreased 18% to $0.83. Full-year net revenue was $2.67 billion, down 16% (9% pro forma). GAAP EPS improved significantly, but adjusted EPS fell 25% to $2.49. A pending acquisition by Lone Star Funds for $3.8 billion is expected to close by Q1 2026. No conference call or FY26 guidance will be provided.

Global-e (GLBE) reported strong Q3 2025 results with GMV reaching $1.512B (+33% YoY) and revenue at $220.8M (+25% YoY). Adjusted EBITDA increased 33% YoY to $41.3M, and free cash flow surged 246% to $73.6M. The company returned to profitability with a net profit of $13.2M. A $200M share repurchase program was authorized. Full-year 2025 guidance was raised to GMV of $6.404-6.524B and revenue of $944.1-960.1M. Q4 2025 guidance and conference call announced for November 19, 2025.

Gaotu Techedu Inc. (GOTU) will release its Q3 2025 financial results on November 26, 2025, before the U.S. market opens. A conference call will follow, focusing on the performance and strategic outlook, especially the adoption of AI-integrated platforms and the impact of regulatory changes. Focus and attention will be placed on Gaotu’s AI-driven strategy, reflecting the broader trend of technological innovation in the Chinese education sector and the company’s diversification efforts in response to previous regulatory restrictions.

Bank Leumi announced strong Q3 2025 financial results, driven by a best-in-class 27% efficiency ratio and 1.3% loan portfolio growth (8.8% YTD). Net income surged 18% to NIS 2.7 billion, with an ROE of 16.3%. The bank declared a NIS 2 billion dividend and maintains robust asset quality with a 0.41% NPL ratio. Capital and liquidity ratios remained solid, with CET1 at 12.33% and LCR at 128%. Leumi also implemented community support initiatives totaling NIS 172 million.